Sebahat Aydil1, Fatma Merih Akpinar2, Evren Akpinar3, Kubilay Beng3, Mehmet Firat Yagmurlu3. 1. Physical Therapy and Rehabilitation, Gait Analysis Laboratory, Metin Sabanci Baltalimani Bone Diseases Education and Research Hospital, Istanbul, Turkey, drsebahataydil@yahoo.com. 2. Physical Therapy and Rehabilitation, Gait Analysis Laboratory, Metin Sabanci Baltalimani Bone Diseases Education and Research Hospital, Istanbul, Turkey. 3. Metin Sabanci Baltalimani Bone Diseases Education and Research Hospital, Pediatric Orthopaedics, Istanbul, Turkey.
Abstract
OBJECTIVE: The aim of the present study was to evaluate the effectiveness of multilevel Botulinum Toxin A (BTX-A) injection, as part of an integrated approach, for the treatment of spasticity in non-ambulatory young children with diplegic cerebral palsy (CP). SUBJECTS AND METHODS: Seventeen non-ambulatory patients aged 4-8 years with diplegic CP (Gross Motor Function Classification System [GMFCS] level IV) were evaluated before and at 1st, 3rd, and 6th months after BTX-A injection. The effect of BTX-A on spasticity of gastrocnemius and hamstring muscles was assessed using the Modified Ashworth Scale (MAS) and Modified Tardieu Scale (MTS). The velocity-dependent properties of spastic muscle as both slow (R2) and fast (R1) stretches were evaluated in MTS. RESULTS: A statistically significant improvement was observed in R1 angles of gastrocnemius and hamstring muscles at 1st and 3rd months after BTX-A injection in non-ambulatory young children with CP. Statistically significant improvement was found in MAS of gastrocnemius and hamstring muscles and R2 angles of knee and ankle joint after 1st month of BTX-A injection. CONCLUSION: Multilevel BTX-A injection, as part of an integrated approach, can be used for focal treatment of spasticity, especially of hamstring and gastrocnemius muscles, in non-ambulatory young children with CP GMFCS level IV.
OBJECTIVE: The aim of the present study was to evaluate the effectiveness of multilevel Botulinum Toxin A (BTX-A) injection, as part of an integrated approach, for the treatment of spasticity in non-ambulatory young children with diplegic cerebral palsy (CP). SUBJECTS AND METHODS: Seventeen non-ambulatory patients aged 4-8 years with diplegic CP (Gross Motor Function Classification System [GMFCS] level IV) were evaluated before and at 1st, 3rd, and 6th months after BTX-A injection. The effect of BTX-A on spasticity of gastrocnemius and hamstring muscles was assessed using the Modified Ashworth Scale (MAS) and Modified Tardieu Scale (MTS). The velocity-dependent properties of spastic muscle as both slow (R2) and fast (R1) stretches were evaluated in MTS. RESULTS: A statistically significant improvement was observed in R1 angles of gastrocnemius and hamstring muscles at 1st and 3rd months after BTX-A injection in non-ambulatory young children with CP. Statistically significant improvement was found in MAS of gastrocnemius and hamstring muscles and R2 angles of knee and ankle joint after 1st month of BTX-A injection. CONCLUSION: Multilevel BTX-A injection, as part of an integrated approach, can be used for focal treatment of spasticity, especially of hamstring and gastrocnemius muscles, in non-ambulatory young children with CP GMFCS level IV.
Authors: S C Love; I Novak; M Kentish; K Desloovere; F Heinen; G Molenaers; S O'Flaherty; H K Graham Journal: Eur J Neurol Date: 2010-08 Impact factor: 6.089
Authors: Peter Rosenbaum; Nigel Paneth; Alan Leviton; Murray Goldstein; Martin Bax; Diane Damiano; Bernard Dan; Bo Jacobsson Journal: Dev Med Child Neurol Suppl Date: 2007-02
Authors: K Desloovere; G Molenaers; I Jonkers; J De Cat; L De Borre; J Nijs; M Eyssen; P Pauwels; P De Cock Journal: Eur J Neurol Date: 2001-11 Impact factor: 6.089
Authors: Vanessa A Scholtes; Annet J Dallmeijer; Dirk L Knol; Lucianne A Speth; Carel G Maathuis; Peter H Jongerius; Jules G Becher Journal: Pediatr Neurol Date: 2007-01 Impact factor: 3.372